echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The purchase of 35 Chinese herbal tablets was suspended, involving American ginseng, cordyceps sinensis, bezoar and so on

    The purchase of 35 Chinese herbal tablets was suspended, involving American ginseng, cordyceps sinensis, bezoar and so on

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On December 16, Shanghai Sunshine Pharmaceutical Procurement Network issued the Notice on Canceling the Medical Insurance Code of Some Chinese Medicine Pieces and Suspension of the Procurement Qualification of the Sunshine Platform, 66 varieties were cancelled the medical insurance code of Chinese medicine pieces, and 35 varieties suspended the procurement qualification
    of the Sunshine Platform for Chinese Medicine Pieces.
     
    According to the announcement, in order to further standardize the management of "sunshine procurement" of Chinese medicine pieces, after sorting out the varieties of Chinese medicine pieces, the Shanghai Pharmaceutical Affairs Institute now cancels a total of 66 varieties (82 product specifications) of the medical insurance code of Chinese medicine pieces, and suspends the procurement qualification of 35 varieties (40 product specifications) of Chinese medicine pieces on the sunshine platform, which will be implemented
    from the date of promulgation.

     
    According to the combing, the Chinese medicine pieces that have been cancelled from the medical insurance code include wild grape root, red diamond shell, underleaf beads, bell grass, saponhorn fungus, fragrant tea cabbage, snake gall, cotton root, wild rice amaranth root, white calamus, tianzhu root, light bamboo leaf root, sunflower root, chrysanthemum root, gardenia root, sheep root, horse root? There are 66 varieties
    such as er, heji, bouldering lotus, dendrobium, sassela flower, elm bark, three-berry bitter, sunflower stalk, gelatin sheet, mutton grass knot, peng fish gill, purple river car powder and so on.

     
    Screenshots of some content (see below for detailed version, download related materials)
     
    The Chinese medicine pieces suspended from procurement include 35 varieties
    , including fried locust rice (flower), yellow lip gum, pearl, wolfberry leaf, lamp charcoal, forest ginseng, red ginseng whisker, red ginseng reed, American ginseng, Inner Mongolian comfrey, cordyceps, deer antler blood tablets, deer antler powder tablets, deer tendon, sand fried leopard bones, sand fried monkey bones, antelope horn tip powder, ox yellow bezoar, monkey jujube powder, bear bile kernel, etc.

     

     
    In addition, on the same day, Shanghai Sunshine Pharmaceutical Procurement Network also issued the Notice on Canceling the Medical Insurance Code of 5 Traditional Chinese Medicine Pieces Varieties including Ganoderma lucidum Powder.


     
    The notice pointed out that according to the requirements of the "Shanghai Municipal Drug Administration on the Suspension of Implementation of the Specification for the Processing of Cardamom Kernel Powder and Other Seven Varieties < Shanghai Traditional Chinese Medicine Pieces >2018 Edition (January 13, 2020)" issued by the Shanghai Municipal Medical Products Administration on January 10, 2020, the Shanghai Pharmaceutical Institute will cancel Ganoderma lucidum powder (drinking tablet code YP0000000004886), cinnamon powder (drinking tablet code YP0602302000884), dog kidney powder ( The medical insurance codes of five varieties of traditional Chinese medicine pieces (YP1002303001029), ginseng powder (drinking tablet code YP0100104000004) and linxia mountain ginseng powder (drinking tablet code YP0100106000006) will be officially implemented
    from January 1, 2023.

     
    It is understood that Chinese medicine pieces are one of the three pillars of
    China's traditional Chinese medicine industry.
    Due to the good mass base, Chinese medicine pieces are widely
    used.
    At the same time, driven by policies such as not being limited by the proportion of drugs and allowing additions, Chinese medicine pieces have shown vigorous development potential
    .
    In recent years, with the tightening of industry supervision and the gradual improvement of the quality standards of traditional Chinese medicine pieces, the 100 billion market may usher in a reshuffle, non-compliant enterprises will be gradually eliminated, and standardized enterprises will achieve rapid development
    .

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
     
    Keyword: The purchase of 35 Chinese herbal tablets was suspended, involving American ginseng, cordyceps sinensis, bezoar and so on , Chinese medicine tablets
    • Next:Stock prices soared more than 2 times! Ibuprofen API company - Hendi Pharmaceutical responded urgently
    • Previous:This pharmaceutical company actively deploys innovative drug research and development, and is expected to add 2~3 new R&D projects every year
     
    [ News Search ] [ Add to favorites ] [ Tell a friend ] [ Print this article ] [ Close Window ]
     
    Similar information

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.